Dapeng Zhou

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 7

Top Topics

Small Cell Lung Cancer

Monoclonal Antibody

Endoplasmic Reticulum Stress

Mass Spectrometry

Top Venues

Rapid communications in mass spectrometry : RCM

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jiao Tong, Chenxi Zhu, Hanyu Lai, Chunchao Feng, Dapeng Zhou
Potent Neutralization Antibodies Induced by a Recombinant Trimeric Spike Protein Vaccine Candidate Containing PIKA Adjuvant for COVID-19. Vaccines 9 (3) (2021)
Dapeng Zhou, Kaijie Xiao, Zhixin Tian
Separation and detection of minimal length glycopeptide neoantigen epitopes centering the GSTA region of MUC1 by liquid chromatography/mass spectrometry. Rapid communications in mass spectrometry : RCM 34 (6) (2020)
Deng Pan, Yubo Tang, Jiao Tong, Chengmei Xie, Jiaxi Chen, Chunchao Feng, Patrick Hwu, Wei Huang, Dapeng Zhou
An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer. Cancer medicine 9 (24) (2020)
Deng Pan, Jiaxi Chen, Chunchao Feng, Weibo Wu, Yanjin Wang, Jiao Tong, Dapeng Zhou
Preferential Localization of MUC1 Glycoprotein in Exosomes Secreted by Non-Small Cell Lung Carcinoma Cells. International journal of molecular sciences 20 (2) (2019)
Deng Pan, Dapeng Zhou, Weijing Cai, Weibo Wu, Wen Ling Tan, Caicun Zhou, Yanyan Lou
Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma. BMC immunology 20 (1) (2019)
Weijing Cai, Dapeng Zhou, Weibo Wu, Wen Ling Tan, Jiaqian Wang, Caicun Zhou, Yanyan Lou
MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine design. BMC genomics 19 (1) (2018)
Dapeng Zhou, Lan Xu, Wei Huang, Torsten Tonn
Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Molecules (Basel, Switzerland) 23 (6) (2018)